{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:31:48Z","timestamp":1779165108402,"version":"3.51.4"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T00:00:00Z","timestamp":1634083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T00:00:00Z","timestamp":1634083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1038\/s41423-021-00773-x","type":"journal-article","created":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T14:57:34Z","timestamp":1634137054000},"page":"2566-2568","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["No crossreactivity of anti-SARS-CoV-2 spike protein antibodies with Syncytin-1"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3048-8540","authenticated-orcid":false,"given":"Mukul","family":"Prasad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia Le","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rashi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Macary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3558-3424","authenticated-orcid":false,"given":"Herbert","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,13]]},"reference":[{"key":"773_CR1","unstructured":"Wodrag W, Yeadon M. Petition\/motion for administrative\/regulatory action regarding confirmation of efficacy end points and use of data in connection with the following clinical trial(s). 2020. https:\/\/2020news.de\/wp-content\/uploads\/2020\/12\/Wodarg_Yeadon_EMA_Petition_Pfizer_Trial_FINAL_01DEC2020_EN_unsigned_with_Exhibits.pdf."},{"key":"773_CR2","unstructured":"Gallaher B. Response to nCoV2019 Against Backdrop of Endogenous Retroviruses. 2020. http:\/\/virological.org\/t\/response-to-ncov2019-against-backdrop-of-endogenous-retroviruses\/396."},{"key":"773_CR3","doi-asserted-by":"publisher","first-page":"6442","DOI":"10.1128\/jvi.76.13.6442-6452.2002","volume":"76","author":"D Lavillette","year":"2002","unstructured":"Lavillette D, Marin M, Ruggieri A, Mallet F, Cosset FL, Kabat D. The envelope glycoprotein of human endogenous retrovirus type W uses a divergent family of amino acid transporters\/cell surface receptors. J Virol. 2002;76:6442\u201352. https:\/\/doi.org\/10.1128\/jvi.76.13.6442-6452.2002.","journal-title":"J Virol"},{"key":"773_CR4","unstructured":"Lu-Culligan, AIA;. in New York Times (26 Jan 2021) 2021. https:\/\/www.nytimes.com\/2021\/01\/26\/opinion\/covid-vaccine-rumors.html."},{"key":"773_CR5","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41577-021-00525-y","volume":"21","author":"V Male","year":"2021","unstructured":"Male V. Are COVID-19 vaccines safe in pregnancy?. Nat Rev Immunol. 2021;21:200\u20131. https:\/\/doi.org\/10.1038\/s41577-021-00525-y.","journal-title":"Nat Rev Immunol"},{"key":"773_CR6","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1074\/mcp.M112.020800","volume":"11","author":"S Buus","year":"2012","unstructured":"Buus S, Rockberg J, Forsstr\u00f6m B, Nilsson P, Uhlen M, Schafer-Nielsen C. High-resolution mapping of linear antibody epitopes using ultrahigh-density peptide microarrays. Mol Cell Proteom. 2012;11:1790\u20131800. https:\/\/doi.org\/10.1074\/mcp.M112.020800.","journal-title":"Mol Cell Proteom"},{"key":"773_CR7","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41577-021-00542-x","volume":"21","author":"PC Taylor","year":"2021","unstructured":"Taylor PC, Adams AC, Hufford MM, de la Torre I, Winthrop K, Gottlieb RL. Neutralizing monoclonal antibodies for treatment of COVID-19. Nat Rev Immunol. 2021;21:382\u201393. https:\/\/doi.org\/10.1038\/s41577-021-00542-x.","journal-title":"Nat Rev Immunol"},{"key":"773_CR8","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/AOG.0000000000004457","volume":"138","author":"ED Shanes","year":"2021","unstructured":"Shanes ED, Otero S, Mithal LB, Mupanomunda CA, Miller ES, Goldstein JA. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in pregnancy: measures of immunity and placental histopathology. Obstet Gynecol. 2021;138:281\u20133. https:\/\/doi.org\/10.1097\/AOG.0000000000004457.","journal-title":"Obstet Gynecol"}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-021-00773-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-021-00773-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-021-00773-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T07:18:47Z","timestamp":1635146327000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-021-00773-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,13]]},"references-count":8,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["773"],"URL":"https:\/\/doi.org\/10.1038\/s41423-021-00773-x","relation":{},"ISSN":["1672-7681","2042-0226"],"issn-type":[{"value":"1672-7681","type":"print"},{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,13]]},"assertion":[{"value":"30 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}